A functional medicine and food homology composition discovery based on disease-related target and data mining against cardiac remodeling

Dan Xiao, Runze Li, Xiaoqing Qin, Jinhai Feng, Denis Baranenko, Liudmila Natdochii, Yingyu Zhou, Jicheng Liu, Yan LinbioRxiv 2024 · DOI

TL;DR

This study identifies β-ecdysterone, a natural compound from "medicine and food homology" (MFH) products, as a promising therapeutic for cardiac remodeling. It achieves this by targeting the NRF2 pathway involved in oxidative stress and also influences central nervous system regulation of the heart, offering a novel approach to cardiovascular disease treatment.

What Problem Does This Paper Address?

Cardiovascular diseases remain a leading cause of death, and cardiac remodeling—the heart's maladaptive response to injury—is a key driver of heart failure. While natural products offer safer alternatives to synthetic drugs, their therapeutic potential for cardiovascular diseases is often unclear due to a lack of robust scientific evidence and systematic screening. This paper aims to bridge this gap by identifying functional MFH compounds that can combat cardiac remodeling, focusing on a comprehensive, high-throughput approach that integrates bioinformatics, computational drug design, and experimental validation.

Methods

The researchers employed a multi-pronged approach:

  • Bioinformatics and Data Mining: They used databases like DisGeNet and GeneCards to identify key targets and pathways in cardiac remodeling, pinpointing oxidative stress and the NRF2 pathway.
  • Computational Drug Design (CADD): They screened a database of MFH compounds (MFCD) for molecules that could competitively bind to KEAP1, thereby releasing NRF2. This involved molecular docking and ADME (Absorption, Distribution, Metabolism, Excretion) predictions.
  • In Vivo and Ex Vivo Experiments: Promising compounds were tested in animal models (ISO-induced cardiac remodeling) and cell cultures (cardiomyocytes, fibroblasts) to assess their efficacy in ameliorating cardiac remodeling, oxidative stress, and inflammation.
  • Transcriptomics: They analyzed gene expression in cardiac and medullary tissues to understand the molecular mechanisms and central-peripheral interactions involved.
  • Neurotransmitter Metabolomics and rs-fMRI: These techniques were used to investigate the impact of the compound on the central nervous system's regulation of cardiac function.
  • Weighted Correlation Network Analysis (WGCNA): This was used to identify key regulatory genes and pathways involved in the central-peripheral crosstalk.

Datasets

  • Medical and Food Homology Compound Database (MFCD): This database was curated by the study, initially containing 110 known MFH natural products and expanded to include 3907 homologous components.
  • Public Databases: DisGeNet, GeneCards, String, Cytoscape, UCSC, PROMO, PubMed, TCMSP, and RCSB (for protein structures).
  • Animal Models: Isoproterenol (ISO)-induced cardiac remodeling in mice, as well as aortic constriction (TAC) and L-NAME-induced hypertension models for initial target validation.

Key Insights and Ideas

  • NRF2 as a Central Player: The study strongly implicates NRF2 as a critical regulator of oxidative stress in cardiac remodeling, making it a prime target for therapeutic intervention.
  • β-ecdysterone's Dual Action: Beyond its direct effects on cardiac cells, β-ecdysterone also influences the central nervous system's regulation of the heart, suggesting a more holistic therapeutic approach.
  • Central-Peripheral Crosstalk: The research highlights the intricate interplay between the central nervous system and the heart in cardiac remodeling, a mechanism that β-ecdysterone appears to modulate.
  • Novel Gene Associations: The study identifies potential roles for genes like Slc41a3 and Dhx37 in cardiac remodeling and their regulation by β-ecdysterone, opening new avenues for research.

Key Results

  • β-ecdysterone Identified: Through CADD and screening, β-ecdysterone was identified as the most promising NRF2 enhancer from the MFCD library.
  • Amelioration of Cardiac Remodeling: β-ecdysterone demonstrated dose-dependent efficacy in ameliorating cardiac hypertrophy and fibrosis in both in vivo and ex vivo models.
  • Reduced Oxidative Stress: The compound effectively countered oxidative stress markers (MDA) and modulated antioxidant enzymes.
  • Central Nervous System Modulation: rs-fMRI showed that β-ecdysterone suppressed activity in the paraventricular nucleus (PVN), a key sympathetic nerve center. Neurotransmitter analysis revealed a decrease in norepinephrine (NE) and its metabolite DHPG.
  • Transcriptomic Signatures: Transcriptome analysis revealed that ISO treatment affected energy metabolism and extracellular matrix remodeling, while β-ecdysterone influenced neurotransmitter-related pathways and genes like Slc41a3 and Dhx37.
  • NRF2 Mediation: Knockdown of NRF2 significantly hindered the beneficial effects of β-ecdysterone on cardiomyocytes, confirming NRF2's mediating role.

Limitations and Future Work

  • Mechanism Research: The authors acknowledge that direct evidence clarifying the specific regulatory relationship of NRF2 with Slc41a3 and Dhx37 in cardiac remodeling and β-ecdysterone treatment was not fully established, emphasizing the need for further in-depth mechanistic research.
  • Data Mining Focus: The study's objective was primarily data mining, meaning extensive mechanism research and verifications were not performed for all identified pathways.
  • Future Directions: The study suggests future research should focus on elucidating the regulatory mechanisms of NRF2, Slc41a3, and Dhx37 in anti-oxidative stress processes and cardiac remodeling. The potential of MFH compounds for cardiovascular diseases warrants further investigation.

Summary updated

Abstract

Abstract Background Medicine and food homological (MFH) products exhibit enhanced safety and tolerability, minimizing notable side effects, making them pivotal for prolonged use in cardiovascular diseases. This study aims to identify functional compounds in MFH based on cardiac remodeling-related target, employing reliable, comprehensive, and high-throughput methods. Methods By bioinformatics and in vivo verifications, we initially investigated the key target in the progression of cardiac remodeling. Subsequently, we performed molecular docking among medical homology compound database (MHCD), and then performed drug-likeness evaluations to recognize functional component based on disease-related target. Pharmacological verifications and data mining including cardiac and medullary transcriptomics, neurotransmitter metabolomics, resting-state functional magnetic resonance imaging (rs-fMRI), and correlationship analysis were utilized to define the benefical effects of MFH functional components, as well as its in-depth mechanims. Results The critical roles of oxidative stress and the key target of NRF2 in cardiac remodeling were discovered, and β-ecdysterone was screened as the most promising NRF2 enhancer in MHCD. Dose-dependent efficacy of β-ecdysterone in countering oxidative stress and ameliorating cardiac remodeling were then verfied by in vivo and ex vivo experiments. By data mining, the crosstalk mechanism between cardiac remodeling and neuromodulation was identified, and further unveiled Slc41a3 as a potential key factor influenced by β-ecdysterone. Additionally, β-ecdysterone mitigated increases in norepinephrine (NE) and its metabolites DHPG in the sympathetic nerve center hypothalamic paraventricular (PVN), as indicated by rs-fMRI. Cardiac and medullary transcriptomes revealed central-peripheral regulation signaling pathways during cardiac remodeling with the involvement of core gene of Dhx37 . Conclusions Our study identified β-ecdysterone as a natural MFH functional compound countering cardiac remodeling by targeting NRF2 elevation. It elucidates crosstalk between cardiac remodeling and neuromodulation, facilitating precise drug screening and mechanistic insights, providing substantial evidence for β-ecdysterone application and molecular mechanisms in cardiovascular diseases.
BibTeX
@misc{xiao2024functional,
  author = {Dan Xiao and Runze Li and Xiaoqing Qin and Jinhai Feng and Denis Baranenko and Liudmila Natdochii and Yingyu Zhou and Jicheng Liu and Yan Lin},
  title = {{A functional medicine and food homology composition discovery based on disease-related target and data mining against cardiac remodeling}},
  year = {2024},
  doi = {10.1101/2024.01.14.575612},
  howpublished = {bioRxiv},
}
Figure